Your browser doesn't support javascript.
loading
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Schmoll, Hans-Joachim; Mann, Julia; Meinert, Fabian; Garlipp, Benjamin; Borchert, Kersten; Vogel, Arndt; Goekkurt, Eray; Kaiser, Ulrich; Hoeffkes, Heinz-Gert; Rüssel, Jörn; Kanzler, Stephan; Edelmann, Thomas; Forstbauer, Helmut; Göhler, Thomas; Hannig, Carla; Hildebrandt, Bert; Roll, Carsten; Bokemeyer, Carsten; Steighardt, Jörg; Cygon, Franziska; Ibach, Stefan; Stein, Alexander; Tintelnot, Joseph.
Afiliação
  • Schmoll HJ; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany.
  • Mann J; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Meinert F; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany.
  • Garlipp B; Department for Surgery, Oberhavel Kliniken Oranienburg, Oranienburg, Germany.
  • Borchert K; Clinic for Oncology/Hematology Klinikum Magdeburg, Magdeburg, Germany.
  • Vogel A; Clinic for Gastroenterology, Medical University Hannover, Hannover, Germany.
  • Goekkurt E; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kaiser U; Clinic for Hematology/Oncology, St. Bernward Krankenhaus, Hildesheim, Germany.
  • Hoeffkes HG; Tumorclinic, Klinikum Fulda, Fulda, Germany.
  • Rüssel J; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany.
  • Kanzler S; Medical Clinic II, Leopoldina Clinic Schweinfurt, Schweinfurt, Germany.
  • Edelmann T; Oncological Practice Schkeuditz, Schkeuditz, Germany.
  • Forstbauer H; Oncological Practice Rheinsieg, Bonn, Germany.
  • Göhler T; Oncological Center Dresden, Dresden, Germany.
  • Hannig C; Oncological Practice Bottrop, Bottrop, Germany.
  • Hildebrandt B; Clinic for Gastroenterology, Hematology and Medical Oncology, Klinikum Barnim, Eberswalde, Germany.
  • Roll C; Clinic for Oncology/Hematology Klinikum Magdeburg, Magdeburg, Germany.
  • Bokemeyer C; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Steighardt J; Coordination Center for Clinical Trials Halle, Medical Faculty, Martin-Luther-University, Halle-Wittenberg, Germany.
  • Cygon F; Clinic for Internal Medicine IV-Hematology/Oncology, University Clinic, Martin-Luther-University, Halle-Wittenberg, Germany.
  • Ibach S; X-act Cologne Clinical Research GmbH, Köln, Germany.
  • Stein A; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tintelnot J; Department of Medicine, Hematology and BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. j.tintelnot@uke.de.
Br J Cancer ; 130(2): 233-241, 2024 02.
Article em En | MEDLINE | ID: mdl-37996507

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2024 Tipo de documento: Article